Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06152458Phase 4Completed
Phase 4, open-label trial of ascorbic acid in septic shock (2 arms), sponsored by University of Pécs. Primary endpoints: Ventilation, Vasopressors and 2 more. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06152458.